FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023

Dec 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-12-26

Reporting Person: RALLIS CHRIS A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-26	Common Shares	S	1390	$10.90	Disposed	44788	Direct
2023-12-26	Common Shares	M	3144	$1.59	Acquired	46178	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-26	Common Shares	$1.59	M	3144	Disposed	2024-01-24	Options (3144)	Direct

Footnotes

F1: Shares sold to satisfy tax obligation on option exercise.

F2: Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.

F3: Represents options granted on January 24, 2014, with a strike price of $1.59 and expiration date of January 24, 2024.